TSB Grant Awarded
30th March 2011
"Deliverics Ltd one of the eight UK companies awarded a TSB Feasibility Study grant of £25,000 under the Responsible Development of Nanotechnologies call. The award, funded by the Technology Strategy Board (TSB) and the Engineering and Physical Sciences Research Council (EPSRC) – will go towards 3-month feasibility studies with the primary purpose of developing Deliverics' next product, an innovative non-toxic delivery reagent for transfecting cells in preclinical models.
Commenting Dr Asier Unciti-Broceta, Deliverics CSO, said "We are absolutely delighted for the support provided by TSB to develop Deliverics' next product. This is probably the most challenging and exciting R&D programme within the company because it will provide a unique tool for the fast-growing in vivo transfection market."
